Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in December 2025 decreased, relative to September 2025 (-6.6%)
As a genetic epidemiological approach, MR can break the limitations of traditional observational studies
Only one thing is for certain: even if GLP-1s go out of style, the associated culture of being skinny, regardless of health risks, is here to stay
Preclinical evidence supports potential efficacy across these substance classes, but human data remain sparse
Although semaglutide is an ingredient in some weight loss medications, Ozempic is specifically for managing type 2 diabetes and not for weight loss
Amongst them, the most studied are photocatalysts based on ZnO